Potential value of PTEN in predicting cetuximab response in colorectal cancer: An exploratory study

200892 citationsJournal Articlegold Open Access

Authors

Evangelia Razis · Hygeia Hospital

Evangelos Briasoulis · University Hospital of Ioannina

Eleni Vrettou · Aristotle University of Thessaloniki

Dimosthenis Skarlos · Henry Dunant Hospital

D. Papamichael · Bank of Cyprus Oncology Center

Ioannis Kostopoulos · Aristotle University of Thessaloniki

Epaminontas Samantas

Abstract

PTEN could be one of the molecular determinants of cetuximab response. Due to the heterogeneity of the population and the retrospective nature of the study, our results are hypothesis generating and should be approached with caution. Further prospective studies are needed to validate this finding.

Topics & Keywords

Colorectal Cancer Treatments and Studies Gastric Cancer Management and Outcomes Cholangiocarcinoma and Gallbladder Cancer Studies

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: BMC Cancer

Volume 8, Issue 1, pp. 234-234

DOI: 10.1186/1471-2407-8-234

Field-Weighted Citation Impact: 6.08